New Key Statistics Module, Z-Score and F-Score
NAS:FULC Key Ratios
Market Cap $ M | 204.36 |
Enterprise Value $ M | -60.70 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.74 |
Price/Sales | 2.49 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 81.00 |
EPS (TTM) $ | -0.35 |
Beneish M-Score | 19.6 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 10.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 1.97 |
EV-to-EBITDA | 2.09 |
PEG | -- |
Shares Outstanding M | 62.40 |
Net Margin (%) | -24.79 |
Operating Margin % | -40.15 |
Pre-tax Margin (%) | -24.79 |
Quick Ratio | 22.07 |
Current Ratio | 22.07 |
ROA % (ttm) | -7.42 |
ROE % (ttm) | -8.07 |
ROIC % (ttm) | -179.58 |
Dividend Yield % | -- |
Altman Z-Score | 4.82 |
FULC Number of Guru Trades
FULC Volume of Guru Trades
Gurus Latest Trades with NAS:FULC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FULC is held by these investors
Total 1
Fulcrum Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FULC
Total 0- 1